Mid-Day Breakouts Report - Wednesday, May 6th, 2020

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Monday, February 26, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

MIDDAY BREAKOUTS REPORT - WEDNESDAY, MAY 6TH, 2020
Previous Mid Day Report Next Mid Day Report >>>

DOW 23870.69 -12.4 (-0.05%) | NASDAQ 8904.04 94.92 (1.08%) | S&P 500 2869.77 1.33 (0.05%)

Time of Screening : 5/6/2020 12:20:54 PM Report Released : 5/6/2020 1:15:20 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 65% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page

NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.

Symbol - Exchange - Industry Group Company Name	Last	Chg	Day High	52 WK Hi	% From Hi	Volume % DAV	DAV
ABBV - NYSE - Medical-Ethical Drugs AbbVie Inc	$87.31	+1.94 2.27%	$88.15	$97.86	-10.78%	8,928,226 67.93%	13,143,000
Most Recent Note for ABBV - 5/6/2020 12:29:00 PM Reported earnings +13% on +10% sales revenues for the Mar '20 quarter. Rebounding toward its all-time high after a deep consolidation since last noted with caution in the 2/10/20 mid-day report - "Quarterly and annual earnings history is not a match with the fact-based investment system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ACLS - NASDAQ - ELECTRONICS - Semiconductor Equipment & Mate Axcelis Technologies Inc	$25.21	+2.46 10.81%	$26.90	$29.24	-13.78%	545,592 163.84%	333,000
Most Recent Note for ACLS - 5/6/2020 12:31:54 PM Reported earnings +83% on +30% sales revenues for the Mar '20 quarter versus the year ago period, but prior quarterly comparisons and annual earnings (C and A criteria) were not a match with the fundamental guidelines of the fact-based investment system.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
AGN - NYSE - DRUGS - Drug Manufacturers - Other Allergan Inc	$195.70	+2.92 1.51%	$196.45	$202.22	-3.22%	4,426,373 97.37%	4,546,000
Most Recent Note for AGN - 5/6/2020 12:33:07 PM Rebounding toward its 52-week high since undercutting its 200 DMA line. Due to report Mar '20 quarterly earnings results on 5/07/20. Prior mid-day reports noted - "Reported earnings +22% on +7% sales revenues for the Dec '19 quarter. Prior quarterly earnings comparisons were well below the +25% minimum guideline (C criteria). After a downturn in FY '14 earnings its growth has been steady."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CHGG - NYSE - Consumer Svcs-Education Chegg Inc	$59.76	+1.84 3.18%	$61.29	$61.33	-2.56%	8,506,733 295.89%	2,875,000
Most Recent Note for CHGG - 5/6/2020 12:34:17 PM Trading up further today after hitting a new all-time high with a considerable "breakaway gap" on the prior session. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Bullish action came after it reported earnings +47% on +35% sales revenues for the Mar '20 quarter. Volume and volatility often increase near earnings news. Went through a choppy consolidation since dropped from the Featured Stocks list on 9/03/19. Fundamentals have remained strong.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
EA - NASDAQ - Computer Sftwr-Gaming Electronic Arts Inc	$113.91	-5.70 -4.77%	$117.16	$120.19	-5.23%	3,925,898 89.86%	4,369,000
Most Recent Note for EA - 5/6/2020 12:38:15 PM Pulling back from its 52-week high hit on the prior session. Reported earnings -18% on +12% sales revenues for the Mar '20 quarter, and prior quarterly comparisons were not strong and steady above the +25% minimum earnings growth guideline (C criteria). Annual earnings (A criteria) history included a downturn in FY '19.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ECOM - NYSE - Computer Sftwr-Enterprse ChannelAdvisor Corp	$10.44	+0.46 4.61%	$10.52	$11.88	-12.12%	220,738 112.05%	197,000
Most Recent Note for ECOM - 5/6/2020 12:39:21 PM Due to report Mar '20 quarterly results on 5/07/20. The 4/30/20 mid-day report noted - "Recent quarterly earnings increases have been strong through Dec '19, but with no sales revenues growth. Erratic annual earnings (A criteria)."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ELMD - AMEX - Medical-Systems/Equip Electromed Inc	$14.71	+0.44 3.08%	$14.75	$15.00	-1.93%	121,629 88.14%	138,000
Most Recent Note for ELMD - 5/6/2020 12:40:07 PM Perched at its 52-week high. Found prompt support near its 200 DMA line and rebounded impressively. Due to report earnings news on 5/12/20. Reported earnings +250% on +7% sales revenues for the quarter ended December 31, 2019 versus the year ago period, a 2nd strong quarterly comparison. Prior quarterly earnings increases were below the fact-based system's +25% minimum guideline (C criteria).
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ENPH - NASDAQ - Energy-Solar Enphase Energy Inc	$52.31	+7.94 17.89%	$52.75	$59.15	-11.56%	6,312,795 97.60%	6,468,000
Most Recent Note for ENPH - 5/6/2020 12:46:51 PM Rebounding impressively toward its 52-week high after a deep pullback. Found support near its 200 DMA line but did not form a sound base pattern. Patient investors may watch for a new base to possibly develop and be noted in the weeks ahead. Reported very strong sales revenues and earnings increases in quarterly comparisons through Mar '20 versus the year ago periods, satisfying the C criteria. Reported earnings in FY '18 and '19 after years of losses.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
GMAB - NASDAQ - Medical-Biomed/Biotech Genmab A/S Ads	$26.05	+1.04 4.14%	$26.36	$25.42	2.46%	386,863 66.59%	581,000
Most Recent Note for GMAB - 5/6/2020 12:48:06 PM Due to report earnings news today Impressively rebounded and it is hitting a new all-time high today after an abrupt retreat. Noted with caution in prior mid-day reports - "Reported earnings +75% on +135% sales revenues for the Dec '19 quarter. Prior history has not been a match with the fundamental guidelines of the fact-based investment system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
IMOS - NASDAQ - ELECTRONICS - Semiconductor Equipment & Mate Chipmos Technologies Ltd	$21.30	+0.45 2.16%	$21.80	$24.83	-14.22%	14,244 71.22%	20,000
Most Recent Note for IMOS - 5/6/2020 12:56:03 PM Faces resistance due to overhead supply up to the $24.83 high hit back in November. Wedging toward its 52-week high with recent gains lacking great volume conviction. This Taiwanese Electronics - Semiconductor Manufacturing firm reported earnings +256% on +27% sales revenues for the Mar '20 quarter versus the year ago period. The past 3 quarterly comparisons show encouraging sales revenues growth rate acceleration, and 3 of the past 4 comparisons had earnings increases above the +25% minimum guideline (C criteria). Annual earnings (A criteria) have improved after a downturn in FY '15 and '16.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
INFU - AMEX - Medical-Services Infusystem Holdings Inc	$12.53	+0.05 0.36%	$12.59	$13.25	-5.47%	55,349 65.12%	85,000
Most Recent Note for INFU - 5/6/2020 12:57:49 PM Consolidating after reaching new highs last week following a deep "V" shaped consolidation, not an orderly base. Due to report Mar '20 quarterly earnings results on 5/14/20. Recent quarterly comparisons through Dec '19 showed improved earnings versus losses for the year ago periods. Annual earnings history has been erratic, not a match with the fact-based investment system's fundamental guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
INSU - NASDAQ - Finance-Blank Check Insurance Acquistion Corp	$10.07	+0.00 0.00%	$10.07	$10.61	-5.09%	950,000 1,727.27%	55,000
Most Recent Note for INSU - 5/6/2020 12:58:14 PM Limited history for this thinly-traded Blank Check company.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
LFVN - NASDAQ - Cosmetics/Personal Care Lifevantage Corp	$15.23	-1.31 -7.92%	$16.19	$17.25	-11.71%	106,475 95.92%	111,000
Most Recent Note for LFVN - 5/6/2020 12:59:56 PM Reported earnings +0% on +0% sales revenues for the Mar '20 quarter versus the year ago period. Recently rebounded near its 52-week high with considerable volume-driven gains. Went through a deep pullback since noted with caution in the 1/31/20 mid-day report - "Showed improved earnings increases in the 3 latest quarterly comparisons through Dec '19, but fundamental concerns remain due to sub par sales revenues growth and its up and down annual earnings (A criteria) history."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
MODN - NYSE - Computer Sftwr-Enterprse Model N Inc	$32.14	+4.66 16.96%	$32.27	$35.84	-10.32%	272,622 79.95%	341,000
Most Recent Note for MODN - 5/6/2020 1:05:11 PM Recent quarterly comparisons through Mar '20 show greatly improved earnings increases and sales revenues growth also improving. It did not form a sound base pattern yet is rebounding impressively toward its 52-week high after a deep pullback. Resistance remains due to overhead supply up to the $36 level.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
NYT - NYSE - MEDIA - Publishing - Newspapers New York Times Co Cl A	$35.59	+2.23 6.68%	$35.67	$40.22	-11.51%	1,218,846 68.74%	1,773,000
Most Recent Note for NYT - 5/6/2020 1:08:03 PM Rebounding toward multi-year highs with a big volume-driven gain today after a deep pullback. Reported Mar '20 earnings -15% on +1% sales versus the year ago period, below the +25% minimum earnings guideline (C criteria). Sub par earnings and sales revenues growth is a fundamental concern. Annual earnings growth slowly and steadily improved after a downturn in FY '16.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
PKI - NYSE - Medical-Research Eqp/Svc Perkinelmer Inc	$94.25	+3.84 4.25%	$96.03	$102.46	-8.01%	723,491 70.38%	1,028,000
Most Recent Note for PKI - 5/6/2020 1:11:32 PM Rebounding toward its 52-week and its all-time highs after a deep pullback. Reported earnings -3% on +1% sales revenues for the Mar '20 quarter, and fundamental concerns remain. Prior quarterly earnings increases were below the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has been gradually improving after a downturn in FY '15.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
REGN - NASDAQ - DRUGS - Biotechnology Regeneron Pharmaceutical	$569.00	-5.37 -0.93%	$569.99	$581.00	-2.07%	1,136,315 76.88%	1,478,000
Most Recent Note for REGN - 5/6/2020 1:11:57 PM Gapped up on the prior session and hit another new 52-week high. Held its ground stubbornly following volume-driven gains. Reported earnings +48% on +33% sales revenues for the Mar '20 quarter versus the year ago period. Prior 4 quarterly comparisons were below the +25% minimum earnings guideline (C criteria). After a downturn in FY '15 earnings its annual earnings (A criteria) growth has been strong.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SFM - NASDAQ - Retail-Super/Mini Mkts Sprouts Farmers Market	$24.43	+2.17 9.75%	$24.45	$22.67	7.76%	3,092,635 114.29%	2,706,000
Most Recent Note for SFM - 5/6/2020 1:13:20 PM Reported earnings +24% on +16% sales revenues for the Mar '20 quarter versus the year ago period. Prior quarterly earnings comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria).
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SLP - NASDAQ - COMPUTER SOFTWARE & SERVICES - Business Software & Services Simulations Plus Inc	$37.11	-1.36 -3.54%	$39.07	$43.63	-14.94%	110,130 67.56%	163,000
Most Recent Note for SLP - 5/6/2020 1:14:10 PM Stalled after hitting a new all-time high last week. Prior mid-day reports noted - "Reported earnings +0% on +22% sales revenues for the Feb '20 quarter versus the year-ago period and fundamental concerns remain. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). Quarterly sales revenues totals have been in the $6-10 million range, growing, but still rather minuscule for publicly traded companies. Has a new CEO effective 6/26/18."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SNFCA - NASDAQ - INSURANCE - Life Insurance Security Natl Finl Cl A	$5.74	+0.14 2.50%	$5.75	$6.42	-10.59%	12,421 112.92%	11,000
Most Recent Note for SNFCA - 5/6/2020 1:14:39 PM Faces resistance due to overhead supply up to $6.40. Prior mid-day reports noted - "Erratic sales revenues and earnings history is not a match with the fact-based investment system's fundamental guidelines. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
TECH - NASDAQ - Medical-Research Eqp/Svc Bio-Techne Corp	$256.79	+10.73 4.36%	$256.79	$247.10	3.92%	208,362 73.37%	284,000
Most Recent Note for TECH - 5/6/2020 1:15:09 PM Hitting another new all-time high with today's 6th consecutive volume-driven gain, but fundamental concerns remain. Reported earnings +15% on +5% sales revenues for the Mar '20 quarter. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based system.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

We appreciate any feedback members may wish to send via the inquiry form here.